自治医科大学附属さいたま医療センターは、埼玉県さいたま市大宮区にある学校法人自治医科大学が運営する病院である。

During the past decade, Jichi Medical University Saitama Medical Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jichi Medical University Saitama Medical Center" #1 sponsor was "Haruhiko Fukuda" with 3 trials, followed by "Chugai Pharmaceutical" with 2 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored and "Japanese Gynecologic Oncology Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jichi Medical University Saitama Medical Center" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 3 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "European Society of Surgical Oncology" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator and "Japan Clinical Oncology Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Jichi Medical University Saitama Medical Center" are "Colorectal Cancer" (2 trials), "Arrhythmias, Cardiac" (1 trials), "Colon Cancer Liver Metastasis" (1 trials), "Colorectal Neoplasms" (1 trials) and "Cytomegalovirus (CMV)" (1 trials). Many other conditions were trialed in "Jichi Medical University Saitama Medical Center" in a lesser frequency.

Most popular intervention types in "Jichi Medical University Saitama Medical Center" are "Drug" (3 trials), "Procedure" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "5FU+l-leucovorin" (1 trials), "CRT-D" (1 trials), "DW-MRI" (1 trials), "ICD" (1 trials) and "Maribavir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jichi Medical University Saitama Medical Center" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Jichi Medical University Saitama Medical Center". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Jichi Medical University Saitama Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jichi Medical University Saitama Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".